Effect of risedronate on the risk of hip fracture in elderly women

New England Journal of Medicine

Volumn 344, Issue 5, 2001, Pages 333-340

  McClung, Michael R ^a,n   Geusens, Piet ^b,c   Miller, Paul D ^d   Zippel, Hartmut ^e   Bensen, William G ^f   Roux, Christian ^g   Adami, Silvano ^h   Fogelman, Ignac ⁱ   Diamond, Terrence ^j   Eastell, Richard ^k   Meunier, Pierre J ^l   Reginster, Jean Yves ^m   Wasnich, Richard D ^o   Greenwald, Maria ^p   Kaufman, Jean Marc ^q   Chestnut III, Charles H ^r  

^a Providence Medical Center   (United States)

^b HASSELT UNIVERSITY   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d University of Colorado Health Sciences Center   (United States)

^e HUMBOLDT UNIVERSITY   (Germany)

^f ST JOSEPH S HOSPITAL   (Canada)

^g Hôpital Cochin ^*  (France)

^h Clinicizzato di Valeggio   (Italy)

ⁱ GUY S HOSPITAL   (United Kingdom)

^j ST GEORGE HOSPITAL   (Australia)

^k UNIVERSITY OF SHEFFIELD   (United Kingdom)

^l EDOUARD HERRIOT HOSPITAL   (France)

^m UNIVERSITY OF LIÈGE   (Belgium)

ⁿ OREGON OSTEOPOROSIS CENTER   (United States)

^o Hawaii Osteoporosis Center   (United States)

^p Osteoporosis Medical Center   (United States)

^q GHENT UNIVERSITY HOSPITAL   (Belgium)

^r UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RISEDRONIC ACID;

AGED; AGING; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FALLING; FEMALE; FEMUR NECK; GAIT; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; BONE DENSITY; CALCIUM CHANNEL BLOCKERS; ETIDRONIC ACID; FEMALE; FRACTURES, BONE; HIP FRACTURES; HUMANS; INCIDENCE; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 0035253489     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200102013440503     Document Type: Article

References (24)

1. A model of lifetime osteoporosis impact
2. Estrogen replacement therapy and fractures in older women: Study of Osteoporotic Fractures Research Group
3. Post-menopausal oestrogens protect against fractures of hip and distal radius: A case-control study
4. Hip fracture and the use of estrogens in postmenopausal women: The Framingham Study
5. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
6. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the fracture intervention trial
7. Risk factors for hip fracture in white women
8. Prediction of osteoporotic fractures by postural instability and bone density
9. How hip and whole-body bone mineral density predict hip fracture in elderly women: The EPIDOS prospective study
10. Fall-related factors and risk of hip fracture: The EPIDOS prospective study
11. Case-control study of risk factors for hip fractures in the elderly
12. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: Recognition of a major effect
13. Body size and hip fracture risk in older women: A prospective study
14. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
15. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized, controlled trial
16. Prevalence of low femoral bone density in older U.S. women from NHANES III
17. Prevalence and incidence of vertebral deformities
18. World-wide projections for hip fracture
19. How many women have osteoporosis?
20. Risk of hip fracture in women with vertebral fracture
21. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
22. 3 and calcium to prevent hip fractures in elderly women
23. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women